New KU startup company focuses on drug that prevents iron absorption into the body - KU Today

Monday, December 19, 2016

New KU startup company focuses on drug that prevents iron absorption into the body
KU Today
LAWRENCE — Bond Biosciences, a new startup based on research done at the University of Kansas, focuses on a new treatment for patients whose bodies absorb too much iron from the food they eat. The new technology is from the lab of Cory Berkland, ...


This news brief sponsored by: MLM Software Central, a division of Inspetta

Tags: startup, company

Comments

Only registered users can leave comments.
Comment text:

DB44 MLM Software by Inspetta